Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12.
Glomerular filtration rate
Nephropathy
Newly diagnosed diabetes
Type 2 diabetes
eGFR decline
Journal
Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
12
01
2021
revised:
08
03
2021
accepted:
16
03
2021
pubmed:
27
3
2021
medline:
17
7
2021
entrez:
26
3
2021
Statut:
ppublish
Résumé
Nephropathy is a complication of type 2 diabetes, with increased albuminuria and reduced glomerular filtration rate (GFR) as biomarkers. Rates of progression to end-stage-renal disease are variable among patients. In this study we have examined the GFR decline in newly diagnosed T2DM. A cohort of 410 patients with newly diagnosed T2DM and with at least four serum creatinine during the follow-up period were recruited. A linear model was used to calculate the decline in eGFR. A multivariable logistic model was used to identify independent predictors of rapid eGFR decline. Average follow-up was 12.4 years. The eGFR change was -0.80 ± 2.23 ml/min/1.73 m A rapid decline in eGFR occurs in approximately 1 out of 10 newly diagnosed subjects. This rapid decline can be predicted by widely accessible clinical features, such as albuminuria. Identification of rapid decliners may help to reduce progression toward advanced stages of nephropathy.
Identifiants
pubmed: 33766697
pii: S0168-8227(21)00131-5
doi: 10.1016/j.diabres.2021.108778
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108778Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.